Dalbavancin
Dalbavancin (INN, trade name Dalvance) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin.The Food and Drug Administration approved dalbavancin for the treatment of acute bacterial skin and skin structure infections caused by certain susceptible bacteria.
| Catalog Number | 10-101-78 |
| Alternative Name(s) | Dalbavancin, Zeven, D03640 |
| Research Area | Dalbavancin can treat patients infected with methicillin-resistant Staphylococcus aureus (MRSA). |
| Molecular Formula | C88H100Cl2N10O28 |
| CAS# | 171500-79-1 |
| Purity | >90% |
| Inchi | InChI=1S/C88H100Cl2N10O28/c1-38(2)13-10-8-6-7-9-11-14-61(106)94-70-73(109)75(111)78(86(120)121)128-87(70)127-77-58-31-43-32-59(77)124-55-24-19-42(29-50(55)89)71(107)69-85(119)98-67(80(114)92-25-12-26-100(4)5)48-33-44(102)34-57(125-88-76(112)74(110)72(108)60(37-101)126-88)62(48)47-28-40(17-22-52(47)103)65(82(116)99-69)95-83(117)66(43)96-84(118)68-49-35-46(36-54(105)63(49)90)123-56-30-41(18-23-53(56)104)64(91-3)81(115)93-51(79(113)97-68)27-39-15-20-45(122-58)21-16-39/h15-24,28-36,38,51,60,64-76,78,87-88,91,101-105,107-112H,6-14,25-27,37H2,1-5H3,(H,92,114)(H,93,115)(H,94,106)(H,95,117)(H,96,118)(H,97,113)(H,98,119)(H,99,116)(H,120,121)/t51-,60-,64-,65-,66-,67?,68+,69+,70-,71-,72-,73-,74+,75+,76+,78+,87-,88+/m0/s1 |
| Inchi Key | KGPGQDLTDHGEGT-CUIWZYKSSA-N |
| SMILES | CC(C)CCCCCCCCC(=O)N[C@H]1[C@@H]([C@H]([C@@H](O[C@@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@@H]([C@@H]6C(=O)NC(C7=CC(=CC(=C7C8=C(C=CC(=C8)[C@@H](C(=O)N6)NC(=O)[C@H]4NC(=O)[C@H]9C1=CC(=CC(=C1Cl)O)OC1=C(C=CC(=C1)[C@@H](C(=O)N[C@@H](CC1=CC=C(O3)C=C1)C(=O)N9)NC)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/dalbavancin-item-10-101-78-32.html |